Source: Eur Respir J, 51 (5) 1800120; 10.1183/13993003.00120-2018
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Signe Vedel-Krogh, Børge G. Nordestgaard, Peter Lange, Jørgen Vestbo, Sune F. Nielsen. Blood eosinophil count and risk of pneumonia hospitalisations in individuals with COPD. Eur Respir J, 51 (5) 1800120; 10.1183/13993003.00120-2018

Member's Comments

No comment yet.

Related content which might interest you: Blood eosinophil count and exacerbation risk in patients with COPD Source: Eur Respir J, 50 (1) 1700761; 10.1183/13993003.00761-2017 Year: 2017 Association between blood eosinophil count and risk of exacerbations in patients with COPD Source: International Congress 2017 – Biomarker-based asthma control Year: 2017 Association between blood eosinophil counts and risk of rehospitalization in patients with asthma Source: International Congress 2017 – Monitoring novel biomarkers in asthma Year: 2017 The impact of high eosinophil count on hospitalizations in COPD patients Source: International Congress 2018 – Biomarkers of COPD Year: 2018 Blood eosinophils in COPD and the future risk of pneumonia Source: Eur Respir J, 52 (1) 1800981; 10.1183/13993003.00981-2018 Year: 2018 Blood eosinophil count predicts treatment failure and hospital readmission for COPD Source: ERJ Open Res, 6 (4) 00188-2020; 10.1183/23120541.00188-2020 Year: 2020 Blood eosinophil counts in COPD patients compared to controls Source: Eur Respir J, 54 (4) 1900633; 10.1183/13993003.00633-2019 Year: 2019 Blood eosinophil count predicts severity of respiratory failure, death and future exacerbations in severe life-threatening asthma Source: International Congress 2018 – Eosinophils in airway disease Year: 2018 Blood eosinophil (EOS) count, exacerbation rate and response to roflumilast in patients with severe COPD Source: International Congress 2017 – What is new in COPD management and prognosis: findings from large studies? Year: 2017 Blood eosinophils and exacerbation rate in COPD patients over three years Source: International Congress 2018 – Biomarkers and lung function in airway disease Year: 2018 Blood vs sputum eosinophils as predictors of exacerbations in a cohort of severe asthmatics Source: International Congress 2018 – Studying novel biomarkers in asthma and COPD Year: 2018 The blood eosinophil count as a biomarker in COPD Source: International Congress 2015 – Individualised risk reduction strategies for patients with COPD Year: 2015 Accuracy of blood eosinophil count in predicting sputum eosinophils in children with problematic severe asthma (PSA) Source: Virtual Congress 2020 – Novel mechanisms and management of paediatric asthma Year: 2020 Blood eosinophil count as a predictor of treatment response in adult patients with chronic cough Source: Virtual Congress 2020 – Asthma and cough: clinical trials and pharmacological insights Year: 2020 Relationship of blood eosinophil count to exacerbations in asthma patients with a COPD diagnosis Source: International Congress 2015 – Epidemiological studies of asthma and allergy Year: 2015 Relationship of blood eosinophil count to exacerbations in COPD Source: International Congress 2016 – Airway response to infection Year: 2016 Elevated blood eosinophils on admission for a severe exacerbation of COPD is not a predictor for survival Source: International Congress 2017 – COPD: from screening to risk factors of lung cancer Year: 2017 Correlation between sputum and blood eosinophils in asthmatic and COPD patients with comorbidities. Source: International Congress 2018 – Airway disease: recent discoveries Year: 2018 Correlations between exacerbation rate and blood eosinophil levels in COPD patients Source: International Congress 2017 – Infection and exacerbation science Year: 2017 Low blood eosinophil count is associated with gram-positive cocci infection and poor clinical outcomes in severe exacerbations of COPD Source: Virtual Congress 2020 – New biomarkers for management of obstructive diseases Year: 2020